- Home
- NKSH vs AMRN Comparison
NKSH vs AMRN Comparison
Compare NKSH & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NKSH | AMRN |
|---|---|---|
| Founded | 1891 | 1989 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 256.1M | 287.9M |
| IPO Year | 1995 | 1998 |
Fundamental Metrics
Financial Performance| Metric | NKSH | AMRN |
|---|---|---|
| Price | $42.48 | $14.04 |
| Analyst Decision | | Strong Sell |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | 29.3K | ★ 79.6K |
| Earning Date | 04-23-2026 | 04-29-2026 |
| Dividend Yield | ★ 4.22% | N/A |
| EPS Growth | ★ 100.81 | 55.00 |
| EPS | ★ 1.57 | N/A |
| Revenue | $8,176,000.00 | ★ $181,104,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.26 |
| P/E Ratio | $26.76 | ★ N/A |
| Revenue Growth | 9.39 | ★ 39.22 |
| 52 Week Low | $27.00 | $12.96 |
| 52 Week High | $43.31 | $20.90 |
Technical Indicators
Market Signals| Indicator | NKSH | AMRN |
|---|---|---|
| Relative Strength Index (RSI) | 58.48 | 47.17 |
| Support Level | $34.90 | $13.59 |
| Resistance Level | $42.90 | $14.55 |
| Average True Range (ATR) | 1.07 | 0.54 |
| MACD | -0.05 | 0.03 |
| Stochastic Oscillator | 90.48 | 36.25 |
Price Performance
Historical ComparisonAbout NKSH National Bankshares Inc.
National Bankshares Inc is a bank holding company. It focuses on lending to small and mid-sized businesses and individuals. The types of loans it offers include commercial and agricultural loans, commercial real estate, construction loans for commercial and residential properties, residential real estate, home equity, and various consumer loan products. It also operates an insurance and brokerage subsidiary. The company earns its revenue from interest and fees on loans, non-interest income, and investments.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a pharmaceutical company. The company is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa. The company focuses on treatments to stop cardiovascular disease causing death, by providing patients, doctors and investors with reliable cardiovascular treatment options. Geographically, the company derives maximum revenue from United States.